Sumitomo Provides $300MM Term Loan to Urovant
Urovant Sciences has entered into a $300 million term loan facility with Sumitomo Dainippon Pharma, a global Japanese pharmaceutical company.
December 31, 2019
Hercules Capital | Sumitomo Dainippon Pharma | Urovant Sciences
nadine